Related references
Note: Only part of the references are listed.Implications of segment mismatch for influenza A virus evolution
Maria C. White et al.
JOURNAL OF GENERAL VIROLOGY (2018)
H7N9 avian influenza A virus in China: a short report on its circulation, drug resistant mutants and novel antiviral drugs
Bao Danqi et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2017)
Novel Cross-Reactive Monoclonal Antibodies against Ebolavirus Glycoproteins Show Protection in a Murine Challenge Model
James Duehr et al.
JOURNAL OF VIROLOGY (2017)
Pathogenicity testing of influenza candidate vaccine viruses in the ferret model
Jessica A. Belser et al.
VIROLOGY (2017)
Deep sequencing of H7N8 avian influenza viruses from surveillance zone supports H7N8 high pathogenicity avian influenza was limited to a single outbreak farm in Indiana during 2016
Dong-Hun Lee et al.
VIROLOGY (2017)
Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for In Vivo Protection in a Serum Transfer Mouse Challenge Model
Henning Jacobsen et al.
MBIO (2017)
Universal influenza virus vaccines: what can we learn from the human immune response following exposure to H7 subtype viruses?
Daniel Stadlbauer et al.
FRONTIERS OF MEDICINE (2017)
Update: Increase in Human Infections with Novel Asian Lineage Avian Influenza A(H7N9) Viruses During the Fifth Epidemic - China, October 1, 2016-August 7, 2017
James C. Kile et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2017)
Vaccination with a Recombinant H7 Hemagglutinin-Based Influenza Virus Vaccine Induces Broadly Reactive Antibodies in Humans
Daniel Stadlbauer et al.
MSPHERE (2017)
Antibody therapies for the prevention and treatment of viral infections
Georgina Salazar et al.
NPJ VACCINES (2017)
The pathogenesis of H7N8 low and highly pathogenic avian influenza viruses from the United States 2016 outbreak in chickens, turkeys and mallards
Mary J. Pantin-Jackwood et al.
PLOS ONE (2017)
Universal influenza virus vaccines and therapeutic antibodies
R. Nachbagauer et al.
CLINICAL MICROBIOLOGY AND INFECTION (2017)
Defining the antibody cross-reactome directed against the influenza virus surface glycoproteins
Raffael Nachbagauer et al.
NATURE IMMUNOLOGY (2017)
Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer Protection
Carole J. Henry Dunand et al.
CELL HOST & MICROBE (2016)
Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection
David J. DiLillo et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Two Outbreak Sources of Influenza A (H7N9) Viruses Have Been Established in China
Dayan Wang et al.
JOURNAL OF VIROLOGY (2016)
H7N9 live attenuated influenza vaccine in healthy adults: a randomised, double-blind, placebo-controlled, phase 1 trial
Larisa Rudenko et al.
LANCET INFECTIOUS DISEASES (2016)
Optimal activation of Fc-mediated effector functions by influenza virus hemagglutinin antibodies requires two points of contact
Paul E. Leon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Broadly-Reactive Neutralizing and Non-neutralizing Antibodies Directed against the H7 Influenza Virus Hemagglutinin Reveal Divergent Mechanisms of Protection
Gene S. Tan et al.
PLOS PATHOGENS (2016)
The pandemic potential of avian influenza A(H7N9) virus: a review
W. D. Tanner et al.
EPIDEMIOLOGY AND INFECTION (2015)
Advances in the development of influenza virus vaccines
Florian Krammer et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
A potent broad-spectrum protective human monoclonal antibody crosslinking two haemagglutinin monomers of influenza A virus
Ying Wu et al.
NATURE COMMUNICATIONS (2015)
Antibodies to Antigenic Site A of Influenza H7 Hemagglutinin Provide Protection against H7N9 Challenge
Falko Schmeisser et al.
PLOS ONE (2015)
Co-infection with Avian (H7N9) and Pandemic (H1N1) 2009 Influenza Viruses, China
Wanju Zhang et al.
EMERGING INFECTIOUS DISEASES (2015)
An H7N1 Influenza Virus Vaccine Induces Broadly Reactive Antibody Responses against H7N9 in Humans
Florian Krammer et al.
CLINICAL AND VACCINE IMMUNOLOGY (2014)
Divergent H7 Immunogens Offer Protection from H7N9 Virus Challenge
Florian Krammer et al.
JOURNAL OF VIROLOGY (2014)
Development of a High-Yield Live Attenuated H7N9 Influenza Virus Vaccine That Provides Protection against Homologous and Heterologous H7 Wild-Type Viruses in Ferrets
Zhongying Chen et al.
JOURNAL OF VIROLOGY (2014)
The M Segment of the 2009 Pandemic Influenza Virus Confers Increased Neuraminidase Activity, Filamentous Morphology, and Efficient Contact Transmissibility to A/Puerto Rico/8/1934-Based Reassortant Viruses
Patricia J. Campbell et al.
JOURNAL OF VIROLOGY (2014)
Assessment of Human Immune Responses to H7 Avian Influenza Virus of Pandemic Potential: Results from a Placebo-Controlled, Randomized Double-Blind Phase I Study of Live Attenuated H7N3 Influenza Vaccine
Larisa Rudenko et al.
PLOS ONE (2014)
Human Co-Infection with Avian and Seasonal Influenza Viruses, China
Jun Li et al.
EMERGING INFECTIOUS DISEASES (2014)
The emergence of H7N9 viruses: a chance to redefine correlates of protection for influenza virus vaccines
Florian Krammer et al.
EXPERT REVIEW OF VACCINES (2013)
Major Challenges in Providing an Effective and Timely Pandemic Vaccine for Influenza A(H7N9)
Michael T. Osterholm et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Correlates of protection to influenza virus, where do we go from here?
Rebecca J. Cox
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
A Pan-H1 Anti-Hemagglutinin Monoclonal Antibody with Potent Broad-Spectrum Efficacy In Vivo
Gene S. Tan et al.
JOURNAL OF VIROLOGY (2012)
A Carboxy-Terminal Trimerization Domain Stabilizes Conformational Epitopes on the Stalk Domain of Soluble Recombinant Hemagglutinin Substrates
Florian Krammer et al.
PLOS ONE (2012)
A Randomized Clinical Trial of an Inactivated Avian Influenza A (H7N7) Vaccine
Robert B. Couch et al.
PLOS ONE (2012)
Attenuated Strains of Influenza A Viruses Do Not Induce Degradation of RNA Polymerase II
Ariel Rodriguez et al.
JOURNAL OF VIROLOGY (2009)
A phase I clinical trial of a PER.C6® cell grown influenza H7 virus vaccine
Rebecca J. Cox et al.
VACCINE (2009)
The annual impact of seasonal influenza in the US: Measuring disease burden and costs
Noelle-Angelique M. Molinari et al.
VACCINE (2007)
Safety evaluation in chickens of candidate human vaccines against potential pandemic strains of influenza
Y Matsouka et al.
AVIAN DISEASES (2003)
Share Paper
